# Baxter International (BAX.US)

Canonical: https://gigainvestors.com/s/BAX

Analysis as of: 2026-10-16T07:26:48.094Z. Financial observations: FY1996–FY2026.

Listing currency: USD. Reporting currency: USD.

## Verdict

Not a wonderful business

Quality tests for Buy: not passed (profit record: fail; earnings resilience is evidence only). Published buy qualification: no.

Share price: $25.76 per share; close as of 2026-10-15.

## Checklist

### understandable: fail

- 1 revenue decline in the last 10 years (informational)

- more than 2 net loss years

- operating margin variation exceeds 0.35

- Financial history: 10 years

- Years with declining revenue: 1

- Years with a net loss: 4

- Operating margin variation: 3.13×

Chart: Operating margin; fiscal year observations.

- FY2017: 0.12×

- FY2018: 0.14×

- FY2019: 0.16×

- FY2020: 0.14×

- FY2021: 0.11×

- FY2022: -0.28×

- FY2023: 0.07×

- FY2024: 0.00×

- FY2025: -0.03×

- LTM to Jun 2026: -0.02×

### moat: fail

- ROIC median below threshold

- ROIC worst years below threshold (more than 1 bad year allowed)

- Recent gross margin fell 9.6pp below the typical margin (limit 4pp)

- ROIC, median of available years: 10.8%

- ROIC, second-lowest year: -2.6%

- Typical minus recent gross margin: 9.6 pp

- Typical gross margin (annual median): 39.7%

- Recent gross margin (lower of latest and 3-year median): 30.1%

- Years with nonpositive capital: 0

- Capital spending / revenue: 6.0%

- ROIC including acquisitions, ten-year median: 9.0%

Chart: ROIC excluding acquisitions; fiscal year observations.

- FY2016: 13.1%

- FY2017: 13.6%

- FY2018: 23.4%

- FY2019: 23.7%

- FY2020: 16.2%

- FY2021: 8.6%

- FY2022: -15.1%

- FY2023: 3.9%

- FY2024: 0.1%

- FY2025: -2.6%

### economics: fail

- incremental invested capital return below threshold

- Cash conversion uses consolidated totals: No

- Owner earnings, five-year total: $2.0B

- Net income, five-year total: -$99M

- Return on incremental invested capital: 0.0%

- Working capital / revenue, annual change: 1.0 pp

- Working capital / revenue, change between three-year averages: 4.6 pp

- Working capital / revenue, final three-year average: 27.2%

Chart: Owner earnings · five years; fiscal year observations.

- FY2021: $1.4B

- FY2022: -$2.0B

- FY2023: $3.2B

- FY2024: -$112M

- FY2025: -$498M

### management: fail

- Historical market-dollar context (not the management verdict): 2016 to 2025 (9 years)

- buybacks unrelated to price (informational)

- ROIC first 3 years vs last 3 years: 13.6% vs 0.1%

- Per-share earnings: 1.76 to -1.27 (three-year endpoint medians)

- per-share value declined or ends nonpositive

- acquired goodwill and intangibles (proxy) exceeds half of ten-year net income with low and deteriorating ROIC

- Management verdict uses per-share economic progress: Yes

- Ordinary dilution, 10-year annual growth: -0.7%

- Ordinary dilution, 5-year annual growth: -0.2%

- Market cap gain: -$15B

- Cumulative retained earnings: -$495M

- Diluted shares, 10-year annual growth: -0.7%

- Diluted shares, 5-year annual growth: -0.2%

- $1 test, starting fiscal year: FY2016

- $1 test, ending fiscal year: FY2025

- Per-share value change: -$3.04

- Per-share value, starting three-year median: $1.76

- Per-share value, ending three-year median: -$1.27

- Buybacks concentrated in cheaper years (correlation): -0.02

- Average buyback yield: 2.0%

- Buyback history: 8 years

- Debt-funded buybacks: No

- Acquisition spending: $14B

- Cumulative net income, 10 years: $9.1B

- ROIC, first three-year median: 13.6%

- ROIC, last three-year median: 0.1%

Chart: Earnings per share; fiscal year observations.

- FY2016: $9.01

- FY2017: $1.08

- FY2018: $2.83

- FY2019: $1.93

- FY2020: $2.13

- FY2021: $2.53

- FY2022: -$4.83

- FY2023: $5.23

- FY2024: -$1.27

- FY2025: -$1.87

### accounting: pass

- Sloan accruals: -9.0%

- Receivables to sales index (DSRI): 1.06×

- Restructuring years, last five: 1

- Stock compensation / operating cash flow: 13.8%

- Earnings backed by cash: Yes

- Accounting red flags: 0

- Goodwill and intangibles / equity: 1.52×

Chart: Sloan accruals; fiscal year observations.

- FY2016: 21.3%

- FY2017: -6.5%

- FY2018: -3.0%

- FY2019: -6.1%

- FY2020: -3.8%

- FY2021: -2.8%

- FY2022: -12.9%

- FY2023: 3.3%

- FY2024: -6.5%

- FY2025: -9.0%

## Holders

- [David Hoeft](https://gigainvestors.com/DAC): tracked 13F investor; follow the investor page for holding quarter and amounts.

- [Steven Romick](https://gigainvestors.com/FPA): tracked 13F investor; follow the investor page for holding quarter and amounts.

- [Edgar Wachenheim](https://gigainvestors.com/GA): tracked 13F investor; follow the investor page for holding quarter and amounts.

- [Mark Hillman](https://gigainvestors.com/HCM): tracked 13F investor; follow the investor page for holding quarter and amounts.

- [Andrew Adams](https://gigainvestors.com/MPF): tracked 13F investor; follow the investor page for holding quarter and amounts.

- [Richard Pzena](https://gigainvestors.com/PIM): tracked 13F investor; follow the investor page for holding quarter and amounts.

- [William Browne](https://gigainvestors.com/TB): tracked 13F investor; follow the investor page for holding quarter and amounts.

## Price story

Down 70% since Dec 2021 · "The medical device company posted weaker-than-expected quarterly earnings and issued dim guidance for 2026." (finance.yahoo.com, Feb 2026) · sales +2%

Story as of 2026-10-16T09:58:22.307Z; price observation 2026-10-15.

- 2025-05-15: BAX Q1 Earnings Call: Revenue Tops Expectations, Margins Face Tariff and Cost Pressures ([finance.yahoo.com](https://finance.yahoo.com/news/bax-q1-earnings-call-revenue-142905931.html))

- 2025-07-31: Baxter cuts forecast, misses estimates amid lingering hurricane impact on medical products unit ([finance.yahoo.com](https://finance.yahoo.com/news/baxter-cuts-forecast-misses-estimates-133205955.html))

- 2025-08-13: BAX Q2 Deep Dive: Margin Pressure and Product Headwinds Temper Near-Term Outlook ([finance.yahoo.com](https://finance.yahoo.com/news/bax-q2-deep-dive-margin-040738456.html))

- 2025-10-31: BAX Q3 Deep Dive: Mixed Segment Results and Lowered Guidance Drive Market Reaction ([finance.yahoo.com](https://finance.yahoo.com/news/bax-q3-deep-dive-mixed-142126920.html))

- 2026-02-12: Baxter shares plunge 14% after earnings miss, weak profit guidance ([finance.yahoo.com](https://finance.yahoo.com/news/baxter-shares-plunge-14-earnings-125743544.html))

- 2026-07-30: Baxter Int'l Q2 Profit Rises; Boosts FY26 Outlook; Stock Surges 15% ([nasdaq.com](https://www.nasdaq.com/articles/baxter-intl-q2-profit-rises-boosts-fy26-outlook-stock-surges-15))

### Sales · FY2025–2026

sales +2%; source https://www.sec.gov/Archives/edgar/data/10456/000162828026007733/bax-20251231.htm; observed 2026-02-12.

- FY2017: $11B 

- FY2018: $11B 

- FY2019: $11B 

- FY2020: $12B 

- FY2021: $12B 

- FY2022: $10B 

- FY2023: $10B 

- FY2024: $11B 

- FY2025: $11B 

- FY2026: $11B 

### Gross margin · FY2025

gross margin 30.1%; source https://www.sec.gov/Archives/edgar/data/10456/000162828026007733/bax-20251231.htm; observed 2026-02-12.

- FY2016: 40.5% 

- FY2017: 42.3% 

- FY2018: 42.9% 

- FY2019: 41.9% 

- FY2020: 39.3% 

- FY2021: 38.9% 

- FY2022: 35.3% 

- FY2023: 40.1% 

- FY2024: 37.5% 

- FY2025: 30.1% 

## Owner memo

Memo as of 2026-10-16T08:06:05.509Z.

### How it makes money

Operates in medical instruments & supplies; annual sales are USD 11.2 billion.

- Source: https://www.sec.gov/Archives/edgar/data/10456/000162828026007733/bax-20251231.htm (filed 2026-02-12); FY2025: revenue 11244000000; grossProfit 3379000000; margin = grossProfit / revenue.

### Why customers stay

Margins ranged from 30.1% to 40.1% during 2023–25; it earns 10.8% on its capital.

- Source: https://eodhd.com/financial-apis/stock-etfs-fundamental-data-feeds/ (filed 2026-02-12); FY2023: grossProfit / revenue = 40.1%.

- Source: https://eodhd.com/financial-apis/stock-etfs-fundamental-data-feeds/ (filed 2026-02-12); FY2024: grossProfit / revenue = 37.5%.

- Source: https://www.sec.gov/Archives/edgar/data/10456/000162828026007733/bax-20251231.htm (filed 2026-02-12); FY2025: grossProfit / revenue = 30.1%.

- Source: https://eodhd.com/financial-apis/stock-etfs-fundamental-data-feeds/ (filed 2026-02-12); 10-year return on capital observations [[2016,0.13125440451021847],[2017,0.13635179153094462],[2018,0.23429288497645936],[2019,0.23696175447980744],[2020,0.16245718852409724],[2021,0.08558882015024305],[2022,-0.15118727297188214],[2023,0.038756175329694165],[2024,0.0008269777179602213],[2025,-0.026341885893688428]]; median 0.10842161233023076. ROIC follows the displayed moat series; financial companies use return on tangible equity.

### Where the cash goes

Paid dividends in 10 of 10 years.

- Source: https://eodhd.com/financial-apis/stock-etfs-fundamental-data-feeds/ (filed 2026-02-12); FY2016: growth capex 0; upkeep 719000000; owner earnings 5046000000. Growth capex / owner earnings = 0.

- Source: https://eodhd.com/financial-apis/stock-etfs-fundamental-data-feeds/ (filed 2026-02-12); FY2017: growth capex 0; upkeep 616000000; owner earnings 736000000. Growth capex / owner earnings = 0.

- Source: https://eodhd.com/financial-apis/stock-etfs-fundamental-data-feeds/ (filed 2026-02-12); FY2018: growth capex 0; upkeep 659000000; owner earnings 1658000000. Growth capex / owner earnings = 0.

- Source: https://eodhd.com/financial-apis/stock-etfs-fundamental-data-feeds/ (filed 2026-02-12); FY2019: growth capex 0; upkeep 696000000; owner earnings 1094000000. Growth capex / owner earnings = 0.

- Source: https://eodhd.com/financial-apis/stock-etfs-fundamental-data-feeds/ (filed 2026-02-12); FY2020: growth capex 0; upkeep 709000000; owner earnings 1216000000. Growth capex / owner earnings = 0.

- Source: https://eodhd.com/financial-apis/stock-etfs-fundamental-data-feeds/ (filed 2026-02-12); FY2021: growth capex 0; upkeep 743000000; owner earnings 1408000000. Growth capex / owner earnings = 0.

- Source: https://eodhd.com/financial-apis/stock-etfs-fundamental-data-feeds/ (filed 2026-02-12); FY2023: growth capex 0; upkeep 436000000; owner earnings 3204000000. Growth capex / owner earnings = 0.

- Source: https://eodhd.com/financial-apis/stock-etfs-fundamental-data-feeds/ (filed 2026-02-12); Dividend observations: [[2016,268000000],[2017,315000000],[2018,376000000],[2019,423000000],[2020,473000000],[2021,530000000],[2022,573000000],[2023,586000000],[2024,590000000],[2025,348000000]]. Zero only counted when supported by a complete cash-flow statement.

### Are managers owners

Insiders own 0.3% of the company.

- Source: https://eodhd.com/financial-apis/stock-etfs-fundamental-data-feeds/ (filed 2026-10-16); BAX.US SharesStats.PercentInsiders = 0.335 percentage points; cache date 2026-10-16.

### What could break it

"We may experience manufacturing, sterilization, supply, or distribution difficulties." (SEC filing, Feb 2026)

- Source: https://www.sec.gov/Archives/edgar/data/10456/000162828026007733/bax-20251231.htm (filed 2026-02-12); We may experience manufacturing, sterilization, supply, or distribution difficulties.

### What the price says

The price is 1.2 times annual sales; cash earnings are negative.

- Source: https://eodhd.com/financial-apis/stock-etfs-fundamental-data-feeds/ (filed 2026-02-12); Closing price 25.76 USD; reporting-to-trading FX 1; FY2025 annual sales per share 21.91812865497076; price multiple 1.1752828175026682. FY2025 cash earnings/share -0.9707602339181286. Closing-price date 2026-10-15.

## Monthly share-price history (USD per share)

- 2016-10: $47.59 per share

- 2016-11: $44.37 per share

- 2016-12: $44.34 per share

- 2017-01: $47.91 per share

- 2017-02: $50.92 per share

- 2017-03: $51.86 per share

- 2017-04: $55.68 per share

- 2017-05: $59.31 per share

- 2017-06: $60.54 per share

- 2017-07: $60.48 per share

- 2017-08: $62.04 per share

- 2017-09: $62.75 per share

- 2017-10: $64.47 per share

- 2017-11: $65.53 per share

- 2017-12: $64.64 per share

- 2018-01: $72.03 per share

- 2018-02: $67.79 per share

- 2018-03: $65.04 per share

- 2018-04: $69.50 per share

- 2018-05: $70.84 per share

- 2018-06: $73.84 per share

- 2018-07: $72.45 per share

- 2018-08: $74.37 per share

- 2018-09: $77.09 per share

- 2018-10: $62.51 per share

- 2018-11: $68.55 per share

- 2018-12: $65.82 per share

- 2019-01: $72.49 per share

- 2019-02: $74.73 per share

- 2019-03: $81.31 per share

- 2019-04: $76.30 per share

- 2019-05: $73.44 per share

- 2019-06: $81.90 per share

- 2019-07: $83.97 per share

- 2019-08: $87.95 per share

- 2019-09: $87.47 per share

- 2019-10: $76.70 per share

- 2019-11: $81.97 per share

- 2019-12: $83.62 per share

- 2020-01: $89.22 per share

- 2020-02: $83.47 per share

- 2020-03: $81.19 per share

- 2020-04: $88.78 per share

- 2020-05: $90.01 per share

- 2020-06: $86.10 per share

- 2020-07: $86.38 per share

- 2020-08: $87.07 per share

- 2020-09: $80.42 per share

- 2020-10: $77.57 per share

- 2020-11: $76.07 per share

- 2020-12: $80.24 per share

- 2021-01: $76.83 per share

- 2021-02: $77.69 per share

- 2021-03: $84.34 per share

- 2021-04: $85.69 per share

- 2021-05: $82.12 per share

- 2021-06: $80.50 per share

- 2021-07: $77.35 per share

- 2021-08: $76.22 per share

- 2021-09: $80.43 per share

- 2021-10: $78.96 per share

- 2021-11: $74.57 per share

- 2021-12: $85.84 per share

- 2022-01: $85.44 per share

- 2022-02: $84.97 per share

- 2022-03: $77.54 per share

- 2022-04: $71.06 per share

- 2022-05: $76.05 per share

- 2022-06: $64.23 per share

- 2022-07: $58.66 per share

- 2022-08: $57.46 per share

- 2022-09: $53.86 per share

- 2022-10: $54.35 per share

- 2022-11: $56.53 per share

- 2022-12: $50.97 per share

- 2023-01: $45.69 per share

- 2023-02: $39.95 per share

- 2023-03: $40.56 per share

- 2023-04: $47.68 per share

- 2023-05: $40.72 per share

- 2023-06: $45.56 per share

- 2023-07: $45.23 per share

- 2023-08: $40.60 per share

- 2023-09: $37.74 per share

- 2023-10: $32.43 per share

- 2023-11: $36.08 per share

- 2023-12: $38.66 per share

- 2024-01: $38.69 per share

- 2024-02: $40.92 per share

- 2024-03: $42.74 per share

- 2024-04: $40.37 per share

- 2024-05: $34.09 per share

- 2024-06: $33.45 per share

- 2024-07: $35.82 per share

- 2024-08: $37.94 per share

- 2024-09: $37.97 per share

- 2024-10: $35.70 per share

- 2024-11: $33.71 per share

- 2024-12: $29.16 per share

- 2025-01: $32.56 per share

- 2025-02: $34.51 per share

- 2025-03: $34.23 per share

- 2025-04: $31.17 per share

- 2025-05: $30.50 per share

- 2025-06: $30.28 per share

- 2025-07: $21.76 per share

- 2025-08: $24.69 per share

- 2025-09: $22.77 per share

- 2025-10: $18.47 per share

- 2025-11: $18.74 per share

- 2025-12: $19.11 per share

- 2026-01: $20.07 per share

- 2026-02: $20.37 per share

- 2026-03: $16.80 per share

- 2026-04: $17.58 per share

- 2026-05: $18.78 per share

- 2026-06: $21.32 per share

- 2026-07: $26.16 per share

- 2026-08: $26.00 per share

- 2026-09: $24.00 per share

- 2026-10: $25.76 per share

## Annual estimated value (USD per share)

- FY2016: low $46.29 per share, central $52.02 per share, high $59.65 per share

- FY2017: low $48.72 per share, central $54.64 per share, high $62.53 per share

- FY2018: low $36.15 per share, central $40.73 per share, high $46.82 per share

- FY2019: low $29.03 per share, central $32.20 per share, high $36.43 per share

- FY2020: low $32.47 per share, central $36.02 per share, high $40.73 per share

- FY2021: low $32.55 per share, central $36.31 per share, high $41.31 per share

- FY2022: low $25.73 per share, central $28.86 per share, high $33.03 per share

- FY2023: low $28.87 per share, central $32.07 per share, high $36.34 per share

- FY2024: low $26.79 per share, central $30.06 per share, high $34.42 per share

Historical values use today's bond yield for every fiscal year

Historical values use today's FX rate into trading currency for every fiscal year

Historical values use current restated fundamentals and current commodity classification; they are not point-in-time estimates

Prior published observations retained from 2026-10-15T06:32:26.082Z where newer inputs omit a numeric field or fiscal period.

## Sources

[Original 10-K filing](https://www.sec.gov/Archives/edgar/data/10456/000162828026007733/bax-20251231.htm); period 2025-12-31, filed 2026-02-12.

Estimates depend on assumptions and are not guarantees or investment advice. Underlying data remains subject to its source licenses; public reading does not grant bulk redistribution rights.

## Reported holder observations

- [David Hoeft](https://gigainvestors.com/DAC): 58,386,345 BAX shares; USD 1,244,797,000 reported position value; 0.65% of portfolio; add; quarter 2026 Q2.
- [Steven Romick](https://gigainvestors.com/FPA): 7,618,145 BAX shares; USD 162,419,000 reported position value; 2.04% of portfolio; add; quarter 2026 Q2.
- [Edgar Wachenheim](https://gigainvestors.com/GA): 14,285,228 BAX shares; USD 304,561,000 reported position value; 3.52% of portfolio; reduce; quarter 2026 Q2.
- [Mark Hillman](https://gigainvestors.com/HCM): 236,032 BAX shares; USD 5,032,000 reported position value; 3.64% of portfolio; reduce; quarter 2026 Q2.
- [Andrew Adams](https://gigainvestors.com/MPF): 12,532 BAX shares; USD 267,000 reported position value; 0% of portfolio; reduce; quarter 2026 Q2.
- [Richard Pzena](https://gigainvestors.com/PIM): 65,295,393 BAX shares; USD 1,392,098,000 reported position value; 4.09% of portfolio; add; quarter 2026 Q2.
- [William Browne](https://gigainvestors.com/TB): 9,479 BAX shares; USD 202,000 reported position value; 0.02% of portfolio; reduce; quarter 2026 Q2.

# BAX — Baxter International Inc.

Held by 7 investors · USD 3,109,376,000 total · 2026 Q2 · reported price USD 21.32 (split-adjusted).
Page: https://gigainvestors.com/s/BAX

## Holders (2026 Q2)

| Investor | Value | % of their portfolio | This quarter |
|---|---:|---:|---|
| Richard Pzena (https://gigainvestors.com/PIM) | USD 1,392,098,000 | 4.1% | add +1.19% |
| David Hoeft (https://gigainvestors.com/DAC) | USD 1,244,797,000 | 0.7% | add +1.98% |
| Edgar Wachenheim (https://gigainvestors.com/GA) | USD 304,561,000 | 3.5% | reduce -0.16% |
| Steven Romick (https://gigainvestors.com/FPA) | USD 162,419,000 | 2.0% | add +13.69% |
| Mark Hillman (https://gigainvestors.com/HCM) | USD 5,032,000 | 3.6% | reduce -4.56% |
| Andrew Adams (https://gigainvestors.com/MPF) | USD 267,000 | 0.0% | reduce -44.41% |
| William Browne (https://gigainvestors.com/TB) | USD 202,000 | <0.1% | reduce -2.67% |

## Total held by quarter

- 2006 Q4: USD 72,233,869 · 1 holder · USD 46.39
- 2007 Q1: USD 59,711,979 · 1 holder · USD 52.67
- 2007 Q2: USD 157,588,614 · 2 holders · USD 56.34
- 2007 Q3: USD 184,074,996 · 2 holders · USD 56.28
- 2007 Q4: USD 195,529,815 · 2 holders · USD 58.05
- 2008 Q1: USD 151,991,434 · 2 holders · USD 57.82
- 2008 Q2: USD 168,079,078 · 2 holders · USD 63.94
- 2008 Q3: USD 181,119,111 · 2 holders · USD 65.63
- 2008 Q4: USD 144,157,100 · 2 holders · USD 53.59
- 2009 Q1: USD 126,907,794 · 2 holders · USD 51.22
- 2009 Q2: USD 38,629,024 · 1 holder · USD 52.96
- 2009 Q3: USD 45,140,518 · 1 holder · USD 57.01
- 2009 Q4: USD 31,992,336 · 1 holder · USD 58.68
- 2010 Q1: USD 42,969,060 · 1 holder · USD 58.20
- 2010 Q2: USD 43,952,160 · 1 holder · USD 40.64
- 2010 Q3: USD 45,558,279 · 1 holder · USD 47.71
- 2010 Q4: USD 36,329,974 · 1 holder · USD 50.62
- 2011 Q1: USD 42,704,134 · 1 holder · USD 53.77
- 2011 Q2: USD 38,667,182 · 1 holder · USD 59.69
- 2011 Q3: USD 36,367,492 · 1 holder · USD 56.14
- 2011 Q4: USD 0 · 0 holders
- 2012 Q1: USD 0 · 0 holders
- 2012 Q2: USD 0 · 0 holders
- 2012 Q3: USD 0 · 0 holders
- 2012 Q4: USD 0 · 0 holders
- 2013 Q1: USD 0 · 0 holders
- 2013 Q2: USD 0 · 0 holders
- 2013 Q3: USD 0 · 0 holders
- 2013 Q4: USD 0 · 0 holders
- 2014 Q1: USD 0 · 0 holders
- 2014 Q2: USD 0 · 0 holders
- 2014 Q3: USD 0 · 0 holders
- 2014 Q4: USD 0 · 0 holders
- 2015 Q1: USD 0 · 0 holders
- 2015 Q2: USD 0 · 0 holders
- 2015 Q3: USD 0 · 0 holders
- 2015 Q4: USD 0 · 0 holders
- 2016 Q1: USD 0 · 0 holders
- 2016 Q2: USD 0 · 0 holders
- 2016 Q3: USD 0 · 0 holders
- 2016 Q4: USD 0 · 0 holders
- 2017 Q1: USD 0 · 0 holders
- 2017 Q2: USD 0 · 0 holders
- 2017 Q3: USD 0 · 0 holders
- 2017 Q4: USD 0 · 0 holders
- 2018 Q1: USD 0 · 0 holders
- 2018 Q2: USD 0 · 0 holders
- 2018 Q3: USD 0 · 0 holders
- 2018 Q4: USD 0 · 0 holders
- 2019 Q1: USD 0 · 0 holders
- 2019 Q2: USD 0 · 0 holders
- 2019 Q3: USD 0 · 0 holders
- 2019 Q4: USD 0 · 0 holders
- 2020 Q1: USD 0 · 0 holders
- 2020 Q2: USD 0 · 0 holders
- 2020 Q3: USD 0 · 0 holders
- 2020 Q4: USD 0 · 0 holders
- 2021 Q1: USD 0 · 0 holders
- 2021 Q2: USD 0 · 0 holders
- 2021 Q3: USD 0 · 0 holders
- 2021 Q4: USD 0 · 0 holders
- 2022 Q1: USD 0 · 0 holders
- 2022 Q2: USD 0 · 0 holders
- 2022 Q3: USD 0 · 0 holders
- 2022 Q4: USD 0 · 0 holders
- 2023 Q1: USD 0 · 0 holders
- 2023 Q2: USD 0 · 0 holders
- 2023 Q3: USD 0 · 0 holders
- 2023 Q4: USD 0 · 0 holders
- 2024 Q1: USD 2,657,984,510 · 6 holders · USD 42.74
- 2024 Q2: USD 2,306,927,214 · 6 holders · USD 33.45
- 2024 Q3: USD 3,298,762,842 · 6 holders · USD 37.97
- 2024 Q4: USD 2,776,570,582 · 7 holders · USD 29.16
- 2025 Q1: USD 3,432,708,260 · 7 holders · USD 34.23
- 2025 Q2: USD 3,144,508,450 · 7 holders · USD 30.28
- 2025 Q3: USD 2,956,010,612 · 7 holders · USD 22.77
- 2025 Q4: USD 2,798,334,147 · 7 holders · USD 19.11
- 2026 Q1: USD 2,403,644,776 · 7 holders · USD 16.80
- 2026 Q2: USD 3,109,376,000 · 7 holders · USD 21.32